Document is current
Any future updates will be listed below
-
Authors
Giménez-Arnau, Ana https://orcid.org/0000-0001-5434-7753
Bewley, Anthony https://orcid.org/0000-0003-1195-0290
Apfelbacher, Christian https://orcid.org/0000-0003-3805-8219
Fargnoli, Maria Concetta https://orcid.org/0000-0002-7249-2556
Rault, Bleuenn https://orcid.org/0000-0003-0423-2899
Morillo, Alexanne https://orcid.org/0009-0007-9101-5636
Maslin, Douglas https://orcid.org/0000-0002-5440-4436
Norlin, Jenny M. https://orcid.org/0000-0001-5402-1884
Crépy, Marie-Noëlle https://orcid.org/0000-0002-9824-1034
Molin, Sonja https://orcid.org/0000-0002-9383-034X
-
Funding
Funding for this research was provided by:
LEO Pharma
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 27 August 2025
First Online: 26 September 2025
Declarations
:
: Ana Giménez-Arnau has received research or advisory funding from Almirall, Amgen, AstraZeneca, Avene, Celldex, Celltrion, Escient Pharmaceuticals, Genentech, GSK, Instituto Carlos III- FEDER, LEO Pharma, Menarini, Mitsubishi Tanabe Pharma, Novartis Sanofi–Regeneron, Servier, Thermo Fisher Scientific, Uriach Pharma / Noucor. Anthony Bewley has had ad hoc consultancy/travel/lecturing agreements with AbbVie, Almirall, BMS, Galderma, Janssen Pharmaceuticals, LEO Pharma, Lilly, MSD, Novartis, Pfizer, Sanofi and UCB. Christian Apfelbacher has received honoraria for consultancy work from Dr Wolff GmbH Bionorica, Sanofi, LEO Pharma, Incyte, Pfizer, Rheacell and IVDK and institutional funding from Dr Wolff GmbH and Bionorica. Maria Concetta Fargnoli has received honoraria or grants from Amgen, Almirall, Abbvie, Boehringer Ingelheim, BMS, Galderma, Kyowa Kyrin, Incyte, LEO Pharma, Pierre Fabre, UCB, Lilly, Pfizer, Janssen, MSD, Novartis, Sanofi, Regeneron, Sun Pharma, Takeda. Marie-Noëlle Crépy has been a consultant, advisory board member, investigator, and/or speaker for AbbVie, LEO Pharma, Pfizer, and Sanofi Genzyme. Sonja Molin has been an investigator and/or has received honoraria as consultant/advisor or speaker and/or grants from Abbvie, Almirall, Alumis, Aralez, Arcutis, Basilea, Bausch and Lomb, Bristol Myer Squibb, Boehringer Ingelheim, Evidera, Galderma, GSK, Incyte, Jamp Biopharma, Janssen, LEO Pharma A/S, Lilly, Moonlake, Novartis, Pfizer, Sanofi, Sun Pharma, and UCB. Bleuenn Rault and Alexanne Morillo are employees of Oracle Life Sciences. Douglas Maslin and Jenny M. Norlin are employees and shareholders of LEO Pharma A/S.
: No personal identifiable information of physicians or patients were recorded. All physicians provided informed consent to proceed with the study. The research was approved by the Cerner Enviza Independent Review Board (IRB) for ethical review (Number 0018).
